IRadimed Corporation (IRMD)
IRadimed Corporation operates in the Medical - Devices industry of the Healthcare sector, headquartered in Orlando, FL, US. The stock last traded at $87.76, down 1.33% on the session, giving a market capitalisation of $1.12B. On trailing twelve-month figures it carries a trailing P/E of 48.22, a net margin of 26.7%. Its beta of 0.91 implies it has historically moved less than the broad market.
IRADIMED CORPORATION specializes in the engineering, production, and distribution of medical devices specifically designed for compatibility with magnetic resonance imaging (MRI) environments. The company supplies these specialized products, alongside their related accessories and support services, to both U.S. and international markets. Key offerings include the MRidium MRI-compatible intravenous (IV) infusion pump system, which comes with disposable tubing sets, and an MRI-compatible patient vital signs monitoring system. Furthermore, IRADIMED provides a range of complementary items such as non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring solutions with sensors. Their clientele primarily consists of hospitals, acute care facilities, and outpatient imaging centers. Sales are conducted via direct field representatives, regional sales directors, clinical support specialists, and independent distributors. Founded in 1992, IRADIMED CORPORATION is headquartered in Winter Springs, Florida.
IRadimed Corporation is most often compared with the following Healthcare names: